Also please be informed the previous sessions have been uploaded at APASL Official YouTube. Please subscribe to our APASL YouTube channel! https://www.youtube.com/channel/UC9b8afc00_jG9J0GBKmMpeQ ++++++++++++++++++++++++++++++++++++++++++++ Please join APASL membership! If you are not yet APASL member, please join APASL! We would appreciate your cooperation for the continuation of our activity. (If you already have been a member of APASL, please disregard this message.) APASL Membership Application is available at https://apasl.info/member/app.php The privileges of APASL members are; for example, online free access to Hepatology International, official journal of the APASL, to receive APASL E-Newsletter with maximum useful information.
Check Out New Articles on COVID-19 and the Liver! New articles on COVID-19 Following new articles on COVID-19 and the liver have been recently published online in Hepatology International.
1. Editorial: Fast, faster, and fastest: science on the run during COVID-19 drama"—"do not forget the liver: https://link.springer.com/article/10.1007/s12072-020-10042-0 2. Consensus: Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation: https://link.springer.com/article/10.1007/s12072-020-10043-z 3. Guidelines: Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the liver transplant Society of India (LTSI): https://link.springer.com/article/10.1007/s12072-020-10041-1 4. SARS-Cov-2 (human) and COVID-19: Primer 2020 https://link.springer.com/article/10.1007/s12072-020-10049-7
"APCOLIS" STUDY
("APASL COVID Liver Injury Spectrum")
Dear colleague
During
this pandemic, the hepatology community is concerned whether their chronic
liver disease/cirrhosis patients who get infected with COVID-19, do
decompensate or not.
To study
the Liver Injury due to COVID-19 infection, we need to record the course and outcome
of each of such patients.
We have prepared a brief survey to address this under the Task Force of APASL.
If you would like to share your individual patient data, please use the monkey
survey.
Each
patient data needs to be filled separately, and would take just about 5
minutes.
The
manuscript policy will be as per international norms.
Do join the “APCOLIS STUDY” of APASL using this web-link. (Clinical Trial Identifier-NCT.)
https://www.surveymonkey.com/r/covid-liver
Dr. Shiv.
K. Sarin, MD, DM
On behalf of APASL | 
INTRO
로그인
회원가입안내
목록
이메일 무단 수집 거부